Nevertheless, the circulating levels of adiponectin, which is the most abundant adipocytokine, are reduced in conditions such as obesity, type 2 diabetes, and coronary heart disease (CHD) [26–28]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.